US Patent Issued to Actinium Phamaceuticals on Sept. 9 for "Low dose antibody-based methods for treating hematologic malignancies" (New York Inventor)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,249, issued on Sept. 9, was assigned to Actinium Phamaceuticals Inc. (New York).

"Low dose antibody-based methods for treating hematologic malignancies" was invented by Dragan Cicic (Brooklyn, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a method for treating a subject afflicted with a hematologic malignancy comprising administering to the subject an agent targeting a hematologic malignancy-associated antigen, wherein the subject has a low peripheral cancerous cell burden. This invention also provides a method for treating a subject afflicted with a hematologic malignancy and having a high peripheral cancerous cell bu...